Celebrex and Vioxx reduce the risk of breast cancer

	Tweet

According to a new study, the regular use of drugs such as Celebrex and Vioxx significantly reduces the risk of breast cancer.

The study by Randall Harris and colleagues from the Ohio State University College of Medicine and Public Health, Columbus, Ohio, the researchers found that the daily use of selective COX-2 inhibitors produced a 71% reduction in the risk of breast cancer.

They also found that drugs such as aspirin and ibuprofen, also reduced the risk of breast cancer but not to the same extent.

The researchers believe the study highlights the potential of non-steroidal anti-inflammatory drugs (NSAIDs) for the prevention of breast cancer.

Harris and colleagues collected data on 323 patients with invasive breast cancer shortly after their diagnosis.

They matched the patients for age, race and county of residence with 649 control individuals with no personal history of cancer.

The data collected on the study group included information on breast cancer risk factors, and the use of selective COX-2 inhibitors and other NSAIDs.

They found that the group of drugs which come under the bracket of selective COX-2 inhibitors, when taken daily for at least two years, reduced the risk of breast cancer.

It appears that a daily dose of 200 mg Celebrex reduced the risk of breast cancer by 83% and a daily dose of 25 mg Vioxx reduced the risk of breast cancer by 64%.

Regular use of aspirin (325 mg), ibuprofen (200mg) and naproxen (250 mg) taken at least every other day for at least five years, also significantly reduced the risk of breast cancer, but less so than regular intake of selective COX-2 inhibitors.

The study is published in the journal BMC Cancer.

RELATED STORIES:
Slight changes in 2 key genes appear to launch breast cancer development   Breast reconstruction may not boost well-being   Acupuncture Reduces Hot Flashes, Improves Sex Drive for Breast Cancer Patients   1-week radiation effective breast cancer treatment   Portable breast scanner allows cancer detection in the blink of an eye   New national poll: 89 percent of women said mammograms vital to their health   Researchers Identify Possible Imaging Method to Stratify Breast Cancer Without Biopsy   Inflammatory Breast Cancer More Rare, More Lethal than Common Form   Breast Reconstruction Varies by Race   Not all women change lifestyle after cancer   Fatigue may persist after breast cancer treatment   DACH1 a key protein for tumor suppression in ER+ breast cancer   Partial Breast Radiation Focus of New Cancer Study   Few high-risk women in U.S. take breast cancer drug   Breast cancer patients prefer silicone over saline implants after mastectomy   Radiation After Mastectomy Improves Breast Cancer Survival   Anti-estrogen Drug Therapy Reduces Risk of Invasive Breast Cancer in Older Women   Targeted breast ultrasound can reduce biopsies for women under 40   Early Breast Cancer Detection Saves Lives   Discovery of a cell mechanism that reduces effectiveness of breast cancer treatment   Genes Linked to Breast Cancer Drug Resistance Could Guide Future Treatment   Genes set scene for metastasis

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]